Measles Initiative Financing 2001-2008 February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.

Slides:



Advertisements
Similar presentations
Progress in Measles Control in the African Region Annual Measles Partnership meeting Feb 2007 Washington DC.
Advertisements

Global Measles and Rubella Strategic Plan
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Supporting Integrated Health Systems Strengthening A CIDA Perspective.
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
District 7630 Rotary International PolioPlus. The status of polio in 1988 Over 350,000 cases of polio reported Rotarians raise $247 million for PolioPlus,
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
Reproductive and Child Health (R&CH) Presented by: Dr. Mariam J. Bakar & Mr. Yusuph Haji.
Challenges in Measles Outbreak Responses MSF Perspectives Florence Fermon - Myriam Henkens 10th Annual Measles Initiative Meeting 14/09/2011.
TRCS EXPERIENCE ON SOCIAL MOBILIZATION FOR INTEGRATED MEASLES CAMPAIGN OF 2011 TANZANIA RED CROSS SOCIETY MEASLES & RUBELLA INITIATIVE MEETING WASHINGTON.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Measles control and elimination in the Eastern Mediterranean Region
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
Malaria Control and Evaluation Partnership for Africa (MACEPA) National Scale-up of Malaria Prevention and Control A Learning Community RBM Board Meeting:
The partners,initiatives, alliances, groups and meetings within world of the Expanded Programme on Immunization Quick overview 25-September-2012 GID presentation.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
World Health Organization
Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
The Measles Initiative American Red Cross IFRC World Youth Meeting 2009.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Strengthening Routine as a Motor for other Interventions A report from Côte d’Ivoire Partners for Measles Advocacy 8 th Annual Meeting Washington DC, 23.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Tessa Wardlaw Working Group on Coverage Monitoring Coverage of Key Child Survival Interventions Tessa Wardlaw.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles Initiative Management and Financing September 13, 2011.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
Funding Update GMMM March 21, 2012 Andrea Gay, UNF Athalia Christie, ARC Rebecca Martin, CDC 1.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
APPLYING LESSONS LEARNED TO FOLLOW-UP CAMPAIGNS, NIGERIA
AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Global Overview of Measles
Measles & Rubella Initiative Partners meeting September 7-8, 2017
POLIOPLUS FACT SHEET Feb 2018
Progress and Challenges with achieving Universal Immunization Coverage
Essential Drugs and Medicines Policy (EDM) World Health Organization
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Polio Eradication Progress & Challenges.
Developing a Financial Sustainability Plan for Cambodia
Presentation transcript:

Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners

SUMMARY OF ACHIEVEMENTS mortality reduction goal achieved 60% reduction worldwide 75% in Africa >360 million children vaccinated in SIAs 2.3 million additional deaths prevented HOW ACHIEVED? Commitment, Proven Strategy and Resources [$] 7th year of partnership meetings 6th year of financial reports Initial 2 years MI had 3 grants/year for WHO AFRO (total nightmare) 3rd year moved to annual budget and to WHO EMRO, SEARO Now in 7th year moving to biannual budget with front-loaded funding to all WHO regions This is PROGRESS!

Measles Initiative Funding History : total $20 million (CDC, ARC, UNF) in AFRO * [20] 2002: total $20 million (CDC, ARC, UNF) plus CIDA $3 million in AFRO [23] 2003: total $18.25 million (CDC, ARC, UNF, Vodafone Fdn) plus CIDA $11.3 million in AFRO; $4.0 million in EMRO/SEARO** [33.55] 2004: total $21.75 million (CDC, ARC,UNF, LDS, Vodafone Fdn, Gates Fdn) plus CIDA $12.4 million in AFRO [34.15] 2005: total $ million (CDC, UNF, ARC, GAVI, Vodafone) plus CIDA $6.3 million in AFRO and EMRO; tsunami funds from ARC totaling $81.2 million for S.E. Asia [ plus 81.2] 2006: total $34.22 million (CDC, UNF, ARC, GAVI, LDS) plus CIDA approx $9 million in AFRO & EMRO [43.22] TOTAL $ million plus country contributions, UNICEF (CDC, JICA, others) * IFRC contributed funds for national RC society volunteers since 2001 ** LDS contributed volunteers in country for campaigns since 2003

Measles Initiative Funds

Year After Year One Question Remains the Same Are anticipated resources sufficient to attain goal? Original 2005 goal attained New GIVS goal of 90% reduction in measles deaths by 2010 (vs. 2000) Additional Regional WHO targets: complete at least one follow-up campaign for all AFRO countries by end of 2009 (unless conflict country) – 30 country follow-ups will be complete by end 2007; all countries start follow-ups by end 2008 complete catch-up (Somalia, Sudan, Pakistan) campaigns in EMRO in 2007 Measles elimination in EMRO and EURO by 2010 Measles elimination in WPRO by 2012 SEARO? Target population during at least 274 million --- more resources available to increase speed and scope of SIA implementation

Measles Initiative Funding

Measles Initiative Funding Outlook : $11,333,000 (CDC, UNF) 2010: $11,333,000 (CDC, UNF) 2007 – 2010 estimated funding need is $479 million (Measles Investment Case II) excluding country contributions (notably India) MI has (if all goes well) $ million through 2010 GAP = $ million minus country contributions [India]

Key Issues and Challenges for Initiative with Funding Implications Lower incidence of measles may lead to declining financial support Increasing costs for SIAs (staff, transport, vaccines, surveillance)?? Sustaining and expanding surveillance – increase costs Increasing country budget support – decrease costs Addressing 2 nd routine dose (potential GAVI/IFFIm funds) – decrease costs Coordination of integration activities and identification of cost savings: increase cost sharing for add-ons to SIAs will decrease cost; with polio will increase costs Defining, piloting integrated M&E methods including routine immunizations, ITN use – increase or decrease costs (who pays?)

Routine Immunization Strengthening Support by Measles Initiative [global increase from 71 to 77% between 1999 and 2005; in Africa, increase from 50 to 65%] Cold chain equipment (carriers, ice packs) EPI staff training (national to local) Injection safety (assessment, AD syringe introduction) Waste management (incinerators) Surveillance (staff, data managers) Laboratory network (equipment, kits) Swaziland example: funds used to improve injection safety skills of EPI staff; printing of tools to initiate RED in all districts for monitoring coverage; supervisor training to prepare for implementation of RED strategy in 2007

Ro utine Immunization Strengthening Measles Initiative Contribution Since 2004, 10% of Measles Initiative funds to WHO AFRO for SIA operational costs are made available to countries to strengthen routine immunization systems during year of SIAs To access these funds, countries submit plans to AFRO for review & approval; funds used primarily for RED (Reaching Every District) activities UNICEF contributes remaining SIA funds for purchase of bundled vaccines, cold chain, social mobilization – amount varies with country and is affected by wastage rate, accuracy of target population, etc In 2006, WHO sent $810,000 to 7 countries Zimbabwe ($40,000), Swaziland ($10,000), Burundi ($25,000), Angola ($75,000), Rwanda ($30,000), DRC ($230,670), Nigeria ($400,000) What about countries who have completed SIAs in previous years? Should MI funds also support these routine systems each year?

Measles Initiative Funding for Case- Based Surveillance in AFRO 2006 Total 35 countries under CB surveillance $824,710 total 2006 contribution $762,710 sent to 26 countries [range $9, ,000] $62,000 additional sent for lab operational costs in 25 countries [$2-3,000/country]

Child Health Interventions Beyond Measles Vaccinations Opportunities Vitamin A (CIDA) Routine immunization strengthening (MP, GAVI, others) OPV (PEI) ITNs – approximately18 million ITNs distributed with measles campaigns Deworming medication (mebendazole from Johnson & Johnson) Others Child Health Days as vehicle – cIMCI Note: Funds for ITNs to distribute during measles campaigns from Global Fund, IFRC, PMI, WB, ExxonMobil, Izumi Fdn, Vodafone Fdn, Mark Gordon, Rotary, UNF’s Nothing But Nets Note: funding is primarily parallel to MP process

Strategy Needed to Close the Funding Gap Goals: GIVS goal of 90% mortality reduction by 2010 Elimination goals of each WHO region with latest date set at 2012 Goals for SEARO and AFRO? What is reasonable to expect from country support? By when? Changes: Implementing at increased speed with increase in funding Preparation process in countries improved with draft POA largely available at start of 2007 Funding disbursed more rapidly – this week almost $100 million is at UN agency HQs and will be sent to regions/countries next week Annual reports received on time this year Increase in country support for operational costs of follow-up campaigns Management:: We have always managed with what we have available – can this continue? What lessons can we use to help with resources (ex: wastage rate) IDEAS ARE WELCOME